Samuel M. Ohayon

Paratus Medical Inc. is the developer of EZResus, an app designed to assist healthcare professionals during the critical first hour of resuscitation. The app aims to alleviate cognitive overload by delegating calculations to a computer and serves as a reference for the entire resuscitation team. EZResus is designed to manage a wide range of patients, providing detailed information and insights for quick access to relevant data.

Founded in 2024, Leaflet Solutions Inc. is dedicated to increasing accessibility to transcatheter mitral valve replacements for patients suffering from moderate to severe regurgitation. The Scalarto catheter will safely modify the anterior leaflet of the mitral valve, preventing left ventricular outflow tract obstruction.

Sensifai Health is a Canadian-Israeli Preemptive Health startup at the forefront of bioconvergence. Its AI-powered platform continuously analyzes data from wearable biometric sensors to deliver early alerts of systemic inflammation before symptoms appear. By identifying silent immune signals in vulnerable individuals, Sensifai enables timely intervention that helps prevent critical health events, reduce hospitalizations, and improve long-term outcomes. https://sensifai.health

Paperplane Therapeutics designs and markets worldwide therapeutic virtual reality experiences aimed at reducing pain and anxiety in patients undergoing medical and dental procedures. Our therapeutic solutions are turnkey, adaptive, scientifically validated and equipped with user data analysis tools.

We provide healthcare organizations with an ecosystem to simplify access to trusted health apps for their patients. Our vision is to become the global reference for data-driven decisions for distributing and reimbursing health apps. TherAppX Review is the world’s most efficient health apps assessment data generation process. AppGuide is where patients and health professionals go for health apps trusted content, assessments and guidance. Healthcare organizations use TherAppX services to create curated health app libraries on AppGuide to simplify patient or employee access to apps that meet their health objectives. Find out more here: https://therappx.com

Paratus Medical Inc. is the developer of EZResus, an app designed to assist healthcare professionals during the critical first hour of resuscitation. The app aims to alleviate cognitive overload by delegating calculations to a computer and serves as a reference for the entire resuscitation team. EZResus is designed to manage a wide range of patients, providing detailed information and insights for quick access to relevant data.

Founded in 2024, Leaflet Solutions Inc. is dedicated to increasing accessibility to transcatheter mitral valve replacements for patients suffering from moderate to severe regurgitation. The Scalarto catheter will safely modify the anterior leaflet of the mitral valve, preventing left ventricular outflow tract obstruction.

Sensifai Health is a Canadian-Israeli Preemptive Health startup at the forefront of bioconvergence. Its AI-powered platform continuously analyzes data from wearable biometric sensors to deliver early alerts of systemic inflammation before symptoms appear. By identifying silent immune signals in vulnerable individuals, Sensifai enables timely intervention that helps prevent critical health events, reduce hospitalizations, and improve long-term outcomes. https://sensifai.health

Paperplane Therapeutics designs and markets worldwide therapeutic virtual reality experiences aimed at reducing pain and anxiety in patients undergoing medical and dental procedures. Our therapeutic solutions are turnkey, adaptive, scientifically validated and equipped with user data analysis tools.

Glen Ventures is a venture capital firm dedicated to investing globally in early-stage Healthcare Technology companies. We are a purpose-driven team of business and clinical leaders, enriched with deep market knowledge and strong industry connections. Our mission is to catalyze innovation across the care continuum, employing a distinct hands-on approach that combines clinical collaboration for co-development, testing, and validation with strategic business guidance to de-risk each stage of growth. As a proud strategic partner to entities affiliated with the McGill University Health Centre (MUHC), Glen Ventures underscores its commitment to fostering healthcare breakthroughs alongside world-class collaborators, accelerating impactful solutions that reshape healthcare.